全文获取类型
收费全文 | 1117篇 |
免费 | 100篇 |
国内免费 | 6篇 |
专业分类
耳鼻咽喉 | 9篇 |
儿科学 | 26篇 |
妇产科学 | 18篇 |
基础医学 | 94篇 |
口腔科学 | 54篇 |
临床医学 | 253篇 |
内科学 | 228篇 |
皮肤病学 | 25篇 |
神经病学 | 50篇 |
特种医学 | 102篇 |
外科学 | 138篇 |
综合类 | 26篇 |
预防医学 | 97篇 |
眼科学 | 15篇 |
药学 | 33篇 |
肿瘤学 | 55篇 |
出版年
2023年 | 10篇 |
2022年 | 9篇 |
2021年 | 19篇 |
2020年 | 11篇 |
2019年 | 16篇 |
2018年 | 25篇 |
2017年 | 19篇 |
2016年 | 19篇 |
2015年 | 28篇 |
2014年 | 40篇 |
2013年 | 55篇 |
2012年 | 36篇 |
2011年 | 46篇 |
2010年 | 46篇 |
2009年 | 32篇 |
2008年 | 52篇 |
2007年 | 49篇 |
2006年 | 37篇 |
2005年 | 41篇 |
2004年 | 29篇 |
2003年 | 22篇 |
2002年 | 37篇 |
2001年 | 36篇 |
2000年 | 19篇 |
1999年 | 34篇 |
1998年 | 33篇 |
1997年 | 42篇 |
1996年 | 39篇 |
1995年 | 19篇 |
1994年 | 25篇 |
1993年 | 18篇 |
1992年 | 28篇 |
1991年 | 14篇 |
1990年 | 18篇 |
1989年 | 18篇 |
1988年 | 19篇 |
1987年 | 18篇 |
1986年 | 19篇 |
1985年 | 23篇 |
1984年 | 15篇 |
1983年 | 8篇 |
1982年 | 14篇 |
1981年 | 8篇 |
1980年 | 13篇 |
1979年 | 5篇 |
1978年 | 11篇 |
1977年 | 10篇 |
1976年 | 11篇 |
1975年 | 7篇 |
1973年 | 6篇 |
排序方式: 共有1223条查询结果,搜索用时 0 毫秒
21.
22.
Corticosteroids have the ability to suppress the production of growth factors and cytokines and are thus implicated in the negative regulation of hematopoiesis. We have shown that the corticosteroids, prednisolone and dexamethasone, were able to effectively protect progenitor cells in four strains of mice against cell-cycle-specific antimetabolic chemotherapy agents. The highest levels of protection against 5-fluorouracil (FU; 200 mg/kg) were achieved when two or three intraperitoneal injections of dexamethasone were administered between - 7 and +3 hours at a dose of 7.5 mg/kg/injection (optimal dose) or by continuous infusion between -4 and +20 hours. This protective effect is manifested as an increase in the number of high proliferative potential colony-forming cells that survive in the bone marrow 3 days after treatment with FU from between 0.5% and 11% to between 10% and 34% of normal. The bone marrow progenitors and blood cell numbers return to normal from 3 to 5 days and 1 to 2 days earlier, respectively. Less dexamethasone than prednisolone is required to give an equivalent protective effect, which is consistent with their anti-inflammatory potency. These findings are further evidence of the negative regulatory role played by corticosteroids, and indicate that the treatment schedules of corticosteroids during cancer therapy need to be reexamined to obtain the maximum benefit from their use. 相似文献
23.
Dr. Elaine B. Feldman MD Regina Watt AB Daniel S. Feldman MD 《Digestive diseases and sciences》1977,22(5):415-418
Effects of bile salts on intestinal glucose transfer differ in diverse animal preparations exposed to various bile acids. Radiolabeled glucose influx into rat jejunum in vitro was studied in buffer and compared to taurodeoxycholate, taurochenodeoxycholate, taurocholate, and deoxycholate. Jejunum was obtained from intact, bile-diverted, and colestipoltreated rats and in similar categories after abdominal x-irradiation. Taurodeoxycholate but not taurocholate inhibited glucose influx only in bile-fistula and colestipol-treated rats. Bile diversion increased and colestipol decreased glucose uptake from buffer. Added inhibitory effects of irradiation and bile salts were seen in bile-fistula animals. These data suggest that normal exposure to bile is chronically inhibiting jejunal glucose transport and that dihydroxy bile salts are responsible for this effect. They do not provide an explanation for the role of bile in the intestinal radiation syndrome.This work was supported in part by contract No. AT-(40-1) 3882 from the U.S. Atomic Energy Commission.These data were presented in part at the annual meeting of the Southern Society for Clinical Investigation, New Orleans, La. February, 1975. 相似文献
24.
25.
26.
27.
28.
Deisseroth AB; Zu Z; Claxton D; Hanania EG; Fu S; Ellerson D; Goldberg L; Thomas M; Janicek K; Anderson WF 《Blood》1994,83(10):3068-3076
Relapse after autologous bone marrow transplantation for chronic myelogenous leukemia (CML) can be due either to the persistence of leukemia cells in systemic tissues following preparative therapy, or due to the persistence of leukemia cells in the autologous marrow used to restore marrow function after intensive therapy. To help distinguish between these two possible causes of relapse, we used safety-modified retroviruses, which contain the bacterial resistance gene NEO, to mark autologous marrow cells that had been collected from patients early in the phase of hematopoietic recovery after in vivo chemotherapy. The cells were then subjected to ex vivo CD34 selection following collection and 30% of the bone marrow were exposed to a safety-modified virus. This marrow was infused after delivery of systemic therapy, which consisted of total body irradiation (1,020 cGy), cyclophosphamide (120 mg/kg), and VP-16 (750 mg/m2). RT PCR assays specific for the bacterial NEO mRNA, which was coded for by the virus, and the bcr-abl mRNA showed that in two evaluable CML patients transplanted with marked cells, sufficient numbers of leukemia cells remained in the infused marrow to contribute to systemic relapse. In addition, both normal and leukemic cells positive for the retroviral transgenome persisted in the systemic circulation of the patients for at least 280 days posttransplant showing that the infused marrow was responsible for the return of hematopoiesis following the preparative therapy. This observation shows that it is possible to use a replication-incompetent safety-modified retrovirus in order to introduce DNA sequences into the hematopoietic cells of patients undergoing autologous bone marrow transplantation. Moreover, this data suggested that additional fractionation procedures will be necessary to reduce the probability of relapse after bone marrow transplantation in at least the advanced stages of the disease in CML patients undergoing autologous bone marrow transplantation procedures. 相似文献
29.
Kate Gridley BA MRes Jenni Brooks MA PhD Caroline Glendinning AB MPhil 《Health & social care in the community》2014,22(6):588-597
This paper reports findings drawn from a study of good practice in English social care for adults with disability and older people with severe and complex needs. People with severe and complex needs are a relatively small proportion of adult social care service users, but they are growing in numbers and have resource‐intensive needs. The study involved qualitative research with adults with disability and older people with severe and complex needs, family carers and members of specialist organisations (n = 67), focusing on the features of social care services they considered to be good practice. Data were collected between August 2010 and June 2011. The approach to data collection was flexible, to accommodate participants' communication needs and preferences, including face‐to‐face and telephone interviews, Talking Mats© sessions and a focus group. Data were managed using Framework and analysed thematically. Features of good practice were considered at three levels: (i) everyday support; (ii) service organisation; and (iii) commissioning. Findings relating to the first two of these are presented here. Participants emphasised the importance of person‐centred ways of working at all levels. Personalisation, as currently implemented in English social care, aims to shift power from professionals to service users through the allocation of personal budgets. This approach focuses very much on the role of the individual in directing his/her own support arrangements. However, participants in this study also stressed the importance of ongoing professional support, for example, from a specialist key worker or case manager to co‐ordinate diverse services and ensure good practice at an organisational level. The paper argues that, despite the recent move to shift power from professionals to service users, people with the most complex needs still value support from professionals and appropriate organisational support. Without these, they risk being excluded from the benefits that personalisation, properly supported, could yield. 相似文献
30.